These prognostic scores are based on prediction factors collected before the cTACE procedure, such as tumor characteristics (e.g., tumor size, vascular invasion), hepatic function (e.g., albumin, bilirubin blood levels), blood markers such as alpha-fetoprotein (AFP), and chronic liver severity indexes such as the Child–Pugh score [30,31]. This evidence concerns the gene AFP and medical procedure.